Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort.

Autor: Nichols CN; Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Lustberg M; Division of Infectious Diseases, Yale New Haven Hospital, New Haven, CT, USA., Sobhanie MME; Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Niermann LJ; Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Gordon M; Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Kman N; Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Parsons J; Department of Internal Medicine, Division of Pulmonary Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Conroy M; Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Dick M; Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Allen J; Department of Internal Medicine, Division of Pulmonary Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Reed E; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Lehman J; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Malvestutto C; Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Publikováno v: Antiviral therapy [Antivir Ther] 2024 Aug; Vol. 29 (4), pp. 13596535241264694.

Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline.

Autor: Nichols CN; Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Wardlow LC; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Coe KE; Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Sobhanie MME; Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2021 Jun 22; Vol. 8 (7), pp. ofab327. Date of Electronic Publication: 2021 Jun 22 (Print Publication: 2021).